Your session is about to expire
← Back to Search
Mental Health Care Bundle for Pediatric Psychiatric Emergency
N/A
Recruiting
Led By Amanda Newton, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 8 to 17.99 years
Be younger than 18 years old
Must not have
Children/youth will also be excluded based on language barriers: Language barrier (i.e., patient and parent/legal guardian must be fluent in either English or French)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days after the index ed visit
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare an acute mental health care bundle to standard care in order to determine if it improves wellbeing in children and youth who seek emergency department care for mental health and substance use concerns.
Who is the study for?
This trial is for children and teens aged 8 to nearly 18 who are experiencing a mental health crisis, such as anxiety, behavioral issues, or thoughts of self-harm. They must speak English or French. It's not for those with schizophrenia-like symptoms, significant self-harm requiring medical attention, substance misuse/intoxication, or other serious medical concerns.
What is being tested?
The study compares an acute mental health care bundle with standard care in emergency departments across Canada. The goal is to see if the new approach better improves wellbeing after 30 days for young people facing mental health and addiction issues.
What are the potential side effects?
Since this trial focuses on health services rather than medication, side effects aren't typical like with drugs. However, there may be emotional or psychological impacts from participating in different types of therapy or interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 8 and 17 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I, and my parent or guardian, can fluently speak English or French.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 and 30 days after the index ed visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 and 30 days after the index ed visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Stirling Children's Wellbeing Scale 30 days after the index ED visit
Warwick-Edinburgh Mental Wellbeing Scale 30 days after the index ED visit
Secondary study objectives
Median duration of the index ED visits
Proportion of children and youth that revisited the emergency department for a mental health complaint related to their index emergency department visit within 7 and 30 days of the index visit
Proportion of emergency department visits for mental healthcare that concluded in hospital admission
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Acute Mental Health Care BundleExperimental Treatment1 Intervention
We developed an evidence-based bundle of care to address current gaps in care. The bundle: 1) brings together multiple evidence-based assessment tools (ASQ, HEADS-ED) to ensure efficient, high-value ED-based care; 2) removes barriers to assessment and builds connections to care: Assessments are conducted by a mental health care provider and families have access to urgent follow-up care; and 3) prioritizes family engagement: A shared decision-making framework (Choice and Partnership) is used to promote children and youth as stewards of their care and support partnership between EDs and follow-up services with the duration of care determined collaboratively by the patient and their provider.
Group II: Usual ED-Based Mental Health CareActive Control1 Intervention
Local standards of ED-based mental health care will be delivered at control sites. Site leads have determined that this care does not involve the 3 specific core innovations in the bundle. Local care standards are similar across study sites and include use of CTAS score at triage (but no mental health risk assessment tool), ED physician medical clearance and assessment of consultation need, and no consistent mental health follow-up plan. Sites that are randomized to the control arm will not adopt core bundle elements.
Find a Location
Who is running the clinical trial?
University of Western Ontario, CanadaOTHER
166 Previous Clinical Trials
312,558 Total Patients Enrolled
Memorial University of NewfoundlandOTHER
71 Previous Clinical Trials
1,829,059 Total Patients Enrolled
Western University, CanadaOTHER
254 Previous Clinical Trials
52,486 Total Patients Enrolled
University of TorontoOTHER
723 Previous Clinical Trials
1,108,788 Total Patients Enrolled
McGill UniversityOTHER
414 Previous Clinical Trials
1,011,880 Total Patients Enrolled
Dalhousie UniversityOTHER
173 Previous Clinical Trials
395,054 Total Patients Enrolled
University of CalgaryLead Sponsor
810 Previous Clinical Trials
879,515 Total Patients Enrolled
University of AlbertaOTHER
942 Previous Clinical Trials
427,609 Total Patients Enrolled
University of SaskatchewanOTHER
257 Previous Clinical Trials
149,291 Total Patients Enrolled
University of ManitobaOTHER
621 Previous Clinical Trials
199,763 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have symptoms of schizophrenia or related disorders.I am experiencing changes in my behavior and physical health, like loss of appetite.I, and my parent or guardian, can fluently speak English or French.I am between 8 and 17 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Usual ED-Based Mental Health Care
- Group 2: Acute Mental Health Care Bundle
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.